DrugMap: A quantitative pan-cancer analysis of cysteine ligandabilityDrugMap serves as a roadmap to develop covalent ligands for oncogenic drivers.DrugMap serves as a roadmap to develop covalent ligands for oncogenic drivers.Mariko Takahashi, Harrison B. Chong, Siwen Zhang, Tzu-Yi Yang, Matthew J. Lazarov, Stefan Harry, Michelle Maynard, Brendan Hilbert, Ryan D. White, Heather E. Murrey, Chih-Chiang Tsou, Kira Vordermark, Jonathan Assaad, Magdy Gohar, Benedikt R. Dürr, Marianne Richter, Himani Patel, Gregory Kryukov, Natasja Brooijmans, Aliyu Sidi Omar Alghali, Karla Rubio, Antonio Villanueva, Junbing Zhang, Maolin Ge, Farah Makram, Hanna Griesshaber, Drew Harrison, Ann-Sophie Koglin, Samuel Ojeda, Barbara Karakyriakou, Alexander Healy, George Popoola, Inbal Rachmin, Neha Khandelwal, Jason R. Neil, Pei-Chieh Tien, Nicholas Chen, Tobias Hosp, Sanne van den Ouweland, Toshiro Hara, Lillian Bussema, Rui Dong, Lei Shi, Martin Q. Rasmussen, Ana Carolina Domingues, Aleigha Lawless, Jacy Fang, Satoshi Yoda, Linh Phuong Nguyen, Sarah Marie Reeves, Farrah Nicole Wakefield, Adam Acker, Sarah Elizabeth Clark, Taronish Dubash, John Kastanos, Eugene Oh, David E. Fisher, Shyamala Maheswaran, Daniel A. Haber, Genevieve M. Boland, Moshe Sade-Feldman, Russell W. Jenkins, Aaron N. Hata, Nabeel M. Bardeesy, Mario L. Suvà, Brent R. Martin, Brian B. Liau, Christopher J. Ott, Miguel N. Rivera, Michael S. Lawrence, Liron Bar-Peledhttps://www.cell.com/cell/fulltext/S0092-8674(24)00318-0?rss=yeshttp://www.cell.com/cell/inpress.rssCellCell RSS feed.Wireless News CampaignApril 23, 2024

Powered by WPeMatico